Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease

Marvin A. Sackner, Ned Greeneltch, Grace Silva, Adam Wanner

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A double-blind crossover comparison was made of the effects of terbutaline, a new adrenergic drug with major action on beta 2 receptors, epinephrine, and saline, on pulmonary function in 16 patients with chronic bronchitis or emphysema and 9 patients with bronchial asthma. Serial determinations of lung volumes, dynamic mechanics of breathing, and distribution of ventilation were made after subcutaneous administration. Terbutaline, 0.5 mg, was a more effective bronchodilator and had a longer duration of action than epinephrine 0.25 mg, but was associated with a higher incidence of side effects. These were generally minor and transient and included tremor, nervousness, and palpitations. Terbutaline may be useful in the management of bronchospasm of asthma, chronic bronchitis, and emphysema.

Original languageEnglish
Pages (from-to)499-506
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume16
Issue number3 PART 1
StatePublished - Sep 1 1974

Fingerprint

Obstructive Lung Diseases
Terbutaline
Bronchodilator Agents
Epinephrine
Chronic Bronchitis
Emphysema
Asthma
Respiratory Mechanics
Bronchial Spasm
Lung
Tremor
Adrenergic Agents
Adrenergic Receptors
Ventilation
Anxiety
Incidence

ASJC Scopus subject areas

  • Pharmacology

Cite this

Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease. / Sackner, Marvin A.; Greeneltch, Ned; Silva, Grace; Wanner, Adam.

In: Clinical Pharmacology and Therapeutics, Vol. 16, No. 3 PART 1, 01.09.1974, p. 499-506.

Research output: Contribution to journalArticle

Sackner, Marvin A. ; Greeneltch, Ned ; Silva, Grace ; Wanner, Adam. / Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease. In: Clinical Pharmacology and Therapeutics. 1974 ; Vol. 16, No. 3 PART 1. pp. 499-506.
@article{447179658812426da84e28f7910f7be4,
title = "Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease",
abstract = "A double-blind crossover comparison was made of the effects of terbutaline, a new adrenergic drug with major action on beta 2 receptors, epinephrine, and saline, on pulmonary function in 16 patients with chronic bronchitis or emphysema and 9 patients with bronchial asthma. Serial determinations of lung volumes, dynamic mechanics of breathing, and distribution of ventilation were made after subcutaneous administration. Terbutaline, 0.5 mg, was a more effective bronchodilator and had a longer duration of action than epinephrine 0.25 mg, but was associated with a higher incidence of side effects. These were generally minor and transient and included tremor, nervousness, and palpitations. Terbutaline may be useful in the management of bronchospasm of asthma, chronic bronchitis, and emphysema.",
author = "Sackner, {Marvin A.} and Ned Greeneltch and Grace Silva and Adam Wanner",
year = "1974",
month = "9",
day = "1",
language = "English",
volume = "16",
pages = "499--506",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "3 PART 1",

}

TY - JOUR

T1 - Bronchodilator effects of terbutaline and epinephrine in obstructive lung disease

AU - Sackner, Marvin A.

AU - Greeneltch, Ned

AU - Silva, Grace

AU - Wanner, Adam

PY - 1974/9/1

Y1 - 1974/9/1

N2 - A double-blind crossover comparison was made of the effects of terbutaline, a new adrenergic drug with major action on beta 2 receptors, epinephrine, and saline, on pulmonary function in 16 patients with chronic bronchitis or emphysema and 9 patients with bronchial asthma. Serial determinations of lung volumes, dynamic mechanics of breathing, and distribution of ventilation were made after subcutaneous administration. Terbutaline, 0.5 mg, was a more effective bronchodilator and had a longer duration of action than epinephrine 0.25 mg, but was associated with a higher incidence of side effects. These were generally minor and transient and included tremor, nervousness, and palpitations. Terbutaline may be useful in the management of bronchospasm of asthma, chronic bronchitis, and emphysema.

AB - A double-blind crossover comparison was made of the effects of terbutaline, a new adrenergic drug with major action on beta 2 receptors, epinephrine, and saline, on pulmonary function in 16 patients with chronic bronchitis or emphysema and 9 patients with bronchial asthma. Serial determinations of lung volumes, dynamic mechanics of breathing, and distribution of ventilation were made after subcutaneous administration. Terbutaline, 0.5 mg, was a more effective bronchodilator and had a longer duration of action than epinephrine 0.25 mg, but was associated with a higher incidence of side effects. These were generally minor and transient and included tremor, nervousness, and palpitations. Terbutaline may be useful in the management of bronchospasm of asthma, chronic bronchitis, and emphysema.

UR - http://www.scopus.com/inward/record.url?scp=50849153377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50849153377&partnerID=8YFLogxK

M3 - Article

C2 - 4606289

AN - SCOPUS:50849153377

VL - 16

SP - 499

EP - 506

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3 PART 1

ER -